CANOPY GROWTH CORP COM NPV (OTCMKTS:TWMJF) has been one of the top plays in the cannabis in North America over the past several months. This is one of the Canadian players, with its headquarters in Smith Falls. Canada, as the reader may be aware, has new major catalysts still out in front in the cannabis and marijuana space.
We are referring to PM Trudeau’s promise to steer Canadian law toward a full recreational legalization of pot sometime in 2017. According to Bloomberg, Canada’s push to legalize marijuana could be a “game changer” for the recreational pot industry with the potential to reach C$6 billion ($4.5 billion) in sales by 2021. TWMJF is a stock with a past littered with sudden rips. Moreover, the company has benefitted from a jump in recent trading volume to the tune of 90% beyond its prior sustained average level. While it has pulled back, our sense is this is a leader in the space with catalysts in front of it, and likely more gains to come.
CANOPY GROWTH CORP COM NPV (OTCMKTS:TWMJF) bills itself as a company that, through its subsidiaries, produces and sells medical marijuana in Canada.
The company offers dry cannabis and oil products primarily under the Tweed and Bedrocan brands. It also sells its products through online.
According to company materials, “Tweed is the most recognized marijuana production brand in the world. It has built a large and loyal following by focusing on quality products and meaningful customer relationships. Tweed doesn’t just sell marijuana, it facilitates a conversation about a product we’ve all heard about but haven’t met intimately yet. It is approachable and friendly, yet reliable and trusted. As marijuana laws liberalize around the world, Tweed will expand its leading Canadian position around the globe.”
Also from their materials, “Bedrocan is the epitome of medical-grade cannabis. Bedrocan BV pioneered medical cannabis in Holland through decades of selection and refinement, leading to standardized, whole bud cannabis strains that patients can rely on. Bedrocan Canada supplies the same standardized strains to the Canadian market through exclusive licensing rights to the American continents, an arrangement it will also enjoy for all future genetic advancements. Due to its consistency over time, Bedrocan’s strains have been used in clinical research in seven European countries. That commitment to research didn’t stay on the east side of the Atlantic – Bedrocan Canada recently launched one of the largest clinical cannabis studies in the world, the EQUAL Study, to evaluate quality of life before and after medical cannabis use.”
The company was formerly known as Tweed Marijuana Inc. and changed its name to Canopy Growth Corporation in September 2015. The company is headquartered in Smiths Falls, Canada.
Find out when $TWMJF stock reaches critical levels. Subscribe to OracleDispatch.com Right Now by entering your Email in the box below.
As we noted last time, Canopy Growth announced earlier this month that it will acquire all of the issued and outstanding shares of Mettrum Health Corp., creating a world-leading diversified cannabis company with six licensed facilities, and a licensed production footprint of approximately 665,000 sq. ft., with significant acreage for expansion. That type of expansionist attitude is crucial when ROI is known to be a tailwind.
The total transaction is valued at approximately C$430 million and will be satisfied by the issuance of common shares in Canopy Growth. Under the terms of the Arrangement Agreement, Mettrum shareholders will be entitled to receive 0.7132 common shares of Canopy Growth for each common share of Mettrum, representing consideration of C$8.42 per Mettrum common share based on the closing price of Canopy Growth common shares on the Toronto Stock Exchange on November 30, 2016. Upon completion of the Arrangement, existing Canopy Growth and Mettrum shareholders are expected to own approximately 77.7% and 22.3%, respectively, of the pro forma company.
At this time, carrying a capital value in the market of $719.9M, TWMJF has a significant war chest ($34.03M) of cash on the books, which compares with an appreciable load ($5.58M) of total accumulated debt. TWMJF is making real money, with trailing 12-month revenues coming in at 18M. In addition, the company is seeing major top line growth, with y/y quarterly revenues growing at 244.6%. We will update the story again soon as developments transpire. For continuing coverage on shares of $TWMJF stock, as well as our other hot stock picks, sign up for our free newsletter today and get our next hot stock pick!